Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117240) titled 'Efficacy and Safety of Minocycline in Patients with Acute Spontaneous Intr... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117244) titled 'Clinical Study on the Application Value of Internal Jugular Vein Ultrasoun... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117248) titled 'Machine Learning Expert System for Early Warning of Sepsis Based on Artifi... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117252) titled 'Research on Precise Exercise Intervention for High-Risk Elderly People wit... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117256) titled 'Real-world Evidence on Semaglutide in the Treatment of Type 2 Diabetes Mel... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117260) titled 'Research on Risk Prediction and Management Strategies of Hip Fractures in ... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117264) titled 'The Effect of Intelligent Warming Strategies Under Perioperative Closed-Lo... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117268) titled 'Exploring the molecular mechanism of PIAS1 regulating ferroptosis by activ... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117272) titled 'A Clinical Comparative Study on the Treatment of Post-Total Knee Replaceme... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117276) titled 'A randomized, double-blind, excipi-controlled, multicenter Phase III clini... Read More